Physician profile
Daniel J Howard
NPI 1245272285
$1,681.80
in general payments reported to CMS, 2019-2025
24 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $268 · 2021: $174 · 2022: $277 · 2023: $48.11 · 2024: $91.89 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $365.91 | 2019-2022 | |
| Stryker Corporation | $275.83 | 2019-2024 | Graftjacket |
| Smith+Nephew, INC. | $271.47 | 2019-2025 | Grafix Pl, Collagenase Santyl, Renasys Touch |
| Wright Medical Technology, INC. | $206.53 | 2019-2020 | |
| Keswick Pharmaceuticals LLC | $61.99 | 2019 | |
| Kerecis Limited | $49.10 | 2021-2022 | |
| Depuy Synthes Sales INC. | $36.97 | 2019-2022 | |
| Bioventus LLC | $36.88 | 2019-2021 | |
| Fidia Pharma USA INC. | $36.20 | 2020-2021 | |
| Convatec INC. | $31.92 | 2025 | |
| Horizon Therapeutics Plc | $31.78 | 2019-2021 | |
| Next Science LLC | $28.58 | 2023 | Blastx, Xperience, Surgx |
| Curonix LLC | $27.32 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Orthofix Medical, INC. | $26.48 | 2022 | |
| Paratek Pharmaceuticals, INC. | $25.00 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.42 | 2022 | |
| Mvp Orthopedics INC | $22.66 | 2022 | |
| Polarityte, INC. | $19.67 | 2020 | |
| Ibsa Pharma INC. | $19.53 | 2023 | Tirosint, Licart |
| Aroa Biosurgery Incorporated | $19.34 | 2025 | |
| Ge Healthcare | $17.55 | 2025 | |
| Mimedx Group, INC. | $17.05 | 2025 | |
| Polymedics Innovations INC. | $15.81 | 2024 | |
| Paragon 28, INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.